Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue

Grail, a company developing blood tests intended to detect cancer well before symptoms show, is taking its pitch to a broader swath of investors. The diagnostics company is looking ahead to potential commercialization of its technology as early as next year, and it has filed for an initial public offering to support its plans. In […]

Click to view original post